21588 ⎘
Preparations containing radioactive substances for use in therapy or testing characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus; Organic compounds; Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins; Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against hormones, hormone-releasing or hormone-inhibiting factors
PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY
#2Pharmaceutical compositions and related methods of delivery
#3Pharmaceutical compositions and related methods of delivery
#4PROVASOPRESSIN ANTAGONISTS AND USES THEREOF
#5Pharmaceutical compositions and related methods of delivery
#6PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY
#7Provasopressin antagonists and uses thereof
#8Labeled ligands of anti-Mullerian hormone for diagnosis of endometriosis
#9Pharmaceutical compositions and related methods of delivery
#10Pharmaceutical compositions and related methods of delivery
#11PROVASOPRESSIN ANTAGONISTS AND USES THEREOF
#12RADIOLABELLING
#13Pharmaceutical compositions and related methods of delivery
#14Pharmaceutical compositions and related methods of delivery
#15METHODS FOR INCREASING EFFICACY OF RADIOIMMUNOTHERAPY OF MELANOMA
#16PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY
#17PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY
#18Radiolabelling